OSL OncoSil Medical Ltd
- 0.013
- +0.001+8.33%
OncoSil Medical Ltd News
OncoSil Medical Ltd: Strong Market Penetration with 30th OncoSil Treatment
OncoSil Medical Ltd: Appointment of Peter Hall as Non-Executive Director
OncoSil Medical Ltd: Appendix 4E Preliminary Financial Report
OncoSil Medical Ltd: Notice of Extraordinary General Meeting/Proxy Form
OncoSil Medical Ltd: Significant Growth in Commercial Treatment Sales in Q4 FY24
OncoSil Medical Ltd: Successful Treatment with OncoSil Device in Turkiye
OncoSil Medical Ltd: Ceasing to be a substantial holder SC
OncoSil Medical Ltd: Prospectus
OncoSil Medical Ltd: Application for quotation of securities - OSL
OncoSil Medical Ltd: Notice of Initial Substantial Holding from SOL
OncoSil Medical Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
OncoSil Medical Ltd: Becoming a substantial holder from PCG
OncoSil Medical Ltd: Notice under section 708A
OncoSil Medical Ltd: Application for quotation of securities - OSL
OncoSil Medical Ltd: Proposed issue of securities - OSL
OncoSil Medical Ltd: Proposed issue of securities - OSL
OncoSil Medical Ltd: Australian institution to invest $2.7 million in OSL
OncoSil Medical Ltd: Investor Presentation
OncoSil Medical Ltd: Peter Hall to be appointed Non-Executive Director (addendum)
OncoSil Medical Ltd: Director Appointment/Resignation PH
Analysis
Price Target
No Data
No Data